AbbVie CEO Richard Gonzalez's 2018 pay slips 6% to $21M
AbbVie reports 2018 executive compensation
By ExecPay News
Published: March 22, 2019
AbbVie reported fiscal year 2018 executive compensation information on March 22, 2019.
In 2018, six AbbVie executives received on average a compensation package of $10M, a 26% decrease compared to previous year.
Average pay of disclosed executives at AbbVie
Richard A. Gonzalez, Chief Executive Officer, received $21M in total, which decreased by 6% compared to 2017. 54% of Gonzalez's compensation, or $12M, was in stock awards. Gonzalez also received $463K of change in pension value and nonqualified deferred compensation earnings, $3.9M in non-equity incentive plan, $2.8M in option awards, $1.7M in salary, as well as $991K in other compensation.
For fiscal year 2018, the median employee pay was $148,823 at AbbVie. Therefore, the ratio of Richard A. Gonzalez's pay to the median employee pay was 143 to one.
Laura J. Schumacher, Chief Legal Officer, received a compensation package of $11M, which decreased by 24% compared to previous year. 36% of the compensation package, or $4.1M, was in stock awards.
Carlos Alban, Chairman, earned $9M in 2018, a 27% decrease compared to previous year.
William J. Chase, Executive Vice President, Finance and Administration, received $8.7M in 2018, which decreases by 28% compared to 2017.
Michael E. Severino, Chairman, earned $8.6M in 2018, a 3% increase compared to previous year.
Robert A. Michael, Chief Financial Officer, received $3.1M in 2018.
Related executives
You may also like
Source: SEC filing on March 22, 2019.